GlassScriptPhysician profile
Robert B Bressler
NPI 1790750636
$2,316.83
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $570 · 2020: $487 · 2021: $638 · 2022: $508 · 2023: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $113.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $340.73 | 2020-2022 | |
| Pfizer INC. | $280.63 | 2019-2023 | |
| Glaxosmithkline, LLC. | $264.38 | 2019-2023 | Trelegy Ellipta, Shingrix |
| Csl Behring | $239.93 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $211.74 | 2019-2023 | Fasenra |
| Teva Pharmaceuticals USA, INC. | $157.00 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $98.96 | 2019-2022 | |
| Genentech USA, INC. | $82.38 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $74.82 | 2019-2021 | |
| Octapharma USA, INC. | $70.92 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $56.18 | 2020-2022 | |
| Optinose US, INC. | $49.79 | 2020-2022 | |
| Uswm, LLC | $49.00 | 2021 | |
| Greer Laboratories, INC. | $45.65 | 2019 | |
| Stryker Corporation | $43.98 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.49 | 2019-2022 | |
| Shire North American Group INC | $39.82 | 2019 | |
| Grifols USA, LLC | $36.18 | 2021-2022 | |
| Phadia US INC. | $34.68 | 2021-2022 | |
| Alk-Abello, INC | $30.92 | 2019-2022 | |
| Kaleo, INC. | $25.41 | 2019 | |
| Boston Scientific Corporation | $17.52 | 2020 | |
| Blueprint Medicines Corporation | $16.03 | 2023 | Ayvakit |
| Itamar Medical INC | $8.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bressler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.